MiR-548t-5p regulates pancreatic ductal adenocarcinoma metastasis through an IL-33-dependent crosstalk between cancer cells and M2 macrophages

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi: 10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584–90. doi: 10.1097/CM9.0000000000002108
   PubMed Web of Science ®Google Scholar
• Zumkeller W, SchofRield PN. Growth factors, cytokines and soluble forms of receptor molecules in cancer patients. Anticancer Res. 1995;15:344–348.
   Web of Science ®Google Scholar
• Finn OJ. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol. 2012;23(Suppl 8):viii6–9. doi: 10.1093/annonc/mds256
   PubMed Web of Science ®Google Scholar
• Bai L, Mao GP, Cao CP. Effects of inflammatory cytokines on the recurrence of liver cancer after an apparently curative operation. J Diges Dis. 2007;8(3):154–159. doi: 10.1111/j.1443-9573.2007.00292.x
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331(6024):1565–70. doi: 10.1126/science.1203486
   PubMed Web of Science ®Google Scholar
• Trotta R, Dal Col J, Yu J, et al. TGF-β utilizes SMAD3 to inhibit CD16-mediated IFN-γ production and Antibody-dependent cellular cytotoxicity in human NK cells. J Immunol. 2008;181(6):3784–3792. doi: 10.4049/jimmunol.181.6.3784
   PubMed Web of Science ®Google Scholar
• Ameri AH, Moradi Tuchayi S, Zaalberg A, et al. IL-33/regulatory T cell axis triggers the development of a tumor-promoting immune environment in chronic inflammation. Proc Natl Acad Sci USA. 2019;116(7):2646–51. doi: 10.1073/pnas.1815016116
   PubMed Web of Science ®Google Scholar
• Saenz SA, Taylor BC, Artis D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev. 2008;226(1):172–90. doi: 10.1111/j.1600-065X.2008.00713.x
   PubMedGoogle Scholar
• Moral JA, Leung J, Rojas LA, et al. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity. Nature. 2020;579(7797):130–5. doi: 10.1038/s41586-020-2015-4
   PubMed Web of Science ®Google Scholar
• Ali S, Mohs A, Thomas M, et al. The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB–Stimulated gene transcription. J Immunol. 2011;187(4):1609–1616. doi: 10.4049/jimmunol.1003080
   PubMed Web of Science ®Google Scholar
• Murakami T, Hiroshima Y, Matsuyama R, et al. Role of the tumor microenvironment in pancreatic cancer. Ann Gastroenterol Surg. 2019;3(2):130–7. doi: 10.1002/ags3.12225
   PubMed Web of Science ®Google Scholar
• Ge WL, Chen Q, Meng LD, et al. The YY1/miR-548t-5p/CXCL11 signaling axis regulates cell proliferation and metastasis in human pancreatic cancer. Cell Death Dis. 2020;11(4):294. doi: 10.1038/s41419-020-2475-3
   PubMed Web of Science ®Google Scholar
• Amirouche A, Ait-Ali D, Nouri H, et al. Trizol-based RNA extraction for detection protocol for SARS-CoV-2 of coronavirus disease 2019. New Microbes New Infect. 2021;41:100874. doi: 10.1016/j.nmni.2021.100874
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Stanojković TP, Matić IZ, Petrović N, et al. Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients. Sci Rep. 2020;10(1):19002. doi: 10.1038/s41598-020-75812-0
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Zhu Y, Xie KL, et al. Yin yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism. Mol Cancer. 2014;13(1):130. doi: 10.1186/1476-4598-13-130
   PubMedGoogle Scholar
• Santoni M, Massari F, Amantini C, et al. Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother. 2013;62(12):1757–68. doi: 10.1007/s00262-013-1487-6
   PubMed Web of Science ®Google Scholar
• Huang X, Li Y, Fu M, et al. Polarizing Macrophages In Vitro. Methods Mol Biol. 2018;1784:119–126.
   PubMedGoogle Scholar
• He Z, Chen L, Souto FO, et al. Epithelial-derived IL-33 promotes intestinal tumorigenesis in apc min/+ mice. Sci Rep. 2017;7(1):5520. doi: 10.1038/s41598-017-05716-z
   PubMed Web of Science ®Google Scholar
• Chan BCL, Lam CWK, Tam LS, et al. IL33: roles in allergic inflammation and therapeutic perspectives. Front Immunol. 2019;10:364. doi: 10.3389/fimmu.2019.00364
   PubMed Web of Science ®Google Scholar
• Park JH, Ameri AH, Dempsey KE, et al. Nuclear IL-33/SMAD signaling axis promotes cancer development in chronic inflammation. EMBO J. 2021;40(7):e106151. doi: 10.15252/embj.2020106151
   PubMed Web of Science ®Google Scholar
• Alonso-Curbelo D, Ho YJ, Burdziak C, et al. A gene–environment-induced epigenetic program initiates tumorigenesis. Nature. 2021;590(7847):642–648. doi: 10.1038/s41586-020-03147-x
   PubMed Web of Science ®Google Scholar
• Schmieder A, Multhoff G, Radons J. Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells. Cytokine. 2012;60(2):514–21. doi: 10.1016/j.cyto.2012.06.286
   PubMed Web of Science ®Google Scholar
• Fang Y, Zhao L, Xiao H, et al. IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer. Med Oncol. 2017;34(2):23. doi: 10.1007/s12032-016-0880-3
   PubMed Web of Science ®Google Scholar
• Liou GY, Bastea L, Fleming A, et al. The presence of interleukin-13 at pancreatic ADM/PanIN lesions alters macrophage populations and mediates pancreatic tumorigenesis. Cell Rep. 2017;19(7):1322–33. doi: 10.1016/j.celrep.2017.04.052
   PubMed Web of Science ®Google Scholar
• Doak GR, Schwertfeger KL, Wood DK. Distant relations: macrophage functions in the metastatic niche. Trends Cancer. 2018;4(6):445–59. doi: 10.1016/j.trecan.2018.03.011
   PubMed Web of Science ®Google Scholar
• Lu CS, Shiau AL, Su BH, et al. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer. J Hematol Oncol. 2020;13(1):62. doi: 10.1186/s13045-020-00887-1
   PubMed Web of Science ®Google Scholar
• Wu JY, Huang TW, Hsieh YT, et al. Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor. Mol Cell. 2020;77(2):213–227. doi: 10.1016/j.molcel.2019.10.023
   PubMed Web of Science ®Google Scholar
• Li M, Li M, Yang Y, et al. Remodeling tumor immune microenvironment via targeted blockade of PI3K-gamma and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy. J Control Release. 2020;321:23–35. doi: 10.1016/j.jconrel.2020.02.011
   PubMed Web of Science ®Google Scholar
• Xu H, Li D, Ma J, et al. The IL-33/ST2 axis affects tumor growth by regulating mitophagy in macrophages and reprogramming their polarization. Cancer Biol Med. 2021;18(1):172–83. doi: 10.20892/j.issn.2095-3941.2020.0211
   PubMed Web of Science ®Google Scholar
• Mai S, Liu L, Jiang J, et al. Oesophageal squamous cell carcinoma–associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase. Cell Prolif. 2021;54(2):e12960. doi: 10.1111/cpr.12960
   PubMed Web of Science ®Google Scholar
• Van der Jeught K, Sun Y, Fang Y, et al. ST2 as checkpoint target for colorectal cancer immunotherapy. JCI Insight. 2020;5(9):e136073. doi: 10.1172/jci.insight.136073
   PubMed Web of Science ®Google Scholar
• Andersson P, Yang Y, Hosaka K, et al. Molecular mechanisms of IL-33–mediated stromal interactions in cancer metastasis. JCI Insight. 2018;3(20):e122375. doi: 10.1172/jci.insight.122375
   PubMed Web of Science ®Google Scholar
• Schwartz C, O’Grady K, Lavelle EC, et al. Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer. Eur J Immunol. 2016;46(5):1091–1100. doi: 10.1002/eji.201545780
   PubMed Web of Science ®Google Scholar
• Yang Z, Grinchuk V, Urban JF Jr, et al. Macrophages as IL-25/IL-33-responsive cells play an important role in the induction of type 2 immunity. PLoS One. 2013;8(3):e59441. doi: 10.1371/journal.pone.0059441
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu H, Zhang H, et al. ST2/IL-33-dependent microglial response limits acute ischemic brain injury. J Neurosci. 2017;37(18):4692–4704. doi: 10.1523/JNEUROSCI.3233-16.2017
   PubMed Web of Science ®Google Scholar
• Hernandez C, Barrachina MD, Cosin-Roger J, et al. Progastrin represses the alternative activation of human macrophages and modulates their influence on colon cancer epithelial cells. PLoS One. 2014;9(6):e98458. doi: 10.1371/journal.pone.0098458
   PubMed Web of Science ®Google Scholar
• Zhu F, Li X, Jiang Y, et al. GdCl3 suppresses the malignant potential of hepatocellular carcinoma by inhibiting the expression of CD206 in tumor-associated macrophages. Oncol Rep. 2015;34(5):2643–2655. doi: 10.3892/or.2015.4268
   PubMed Web of Science ®Google Scholar
• Allavena P, Sica A, Solinas G, et al. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2017;66(1):1–9. doi: 10.1016/j.critrevonc.2007.07.004
   Google Scholar
• Genin M, Clement F, Fattaccioli A, et al. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 2015;15(1):577. doi: 10.1186/s12885-015-1546-9
   PubMedGoogle Scholar
• Wang Z, Xu L, Hu Y, et al. miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer. Sci Rep. 2016;6(1):25602. doi: 10.1038/srep25602
   PubMedGoogle Scholar
• Gao Y, Fang P, Li WJ, et al. LncRNA NEAT1 sponges miR-214 to regulate M2 macrophage polarization by regulation of B7-H3 in multiple myeloma. Mol Immunol. 2020;117:20–28. doi: 10.1016/j.molimm.2019.10.026
   PubMed Web of Science ®Google Scholar
• Wu H, Xu JB, He YL, et al. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol. 2012;106(4):462–8. doi: 10.1002/jso.23110
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–37. doi: 10.1038/nm.3394
   PubMed Web of Science ®Google Scholar
• Wang J, Li DY, Cang HX, et al. Crosstalk between cancer and immune cells: role of tumor-associated macrophages in the tumor microenvironment. Cancer Med. 2019;8(10):4709–21. doi: 10.1002/cam4.2327
   PubMed Web of Science ®Google Scholar
• De Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell. 2013;23(3):277–86. doi: 10.1016/j.ccr.2013.02.013
   PubMed Web of Science ®Google Scholar
• Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49–61. doi: 10.1016/j.immuni.2014.06.010
   PubMed Web of Science ®Google Scholar
• Susen RM, Bauer R, Olesch C, et al. Macrophage HIF-2α regulates tumor-suppressive Spint1 in the tumor microenvironment. Mol Carcinog. 2019;58(11):2127–2138. doi: 10.1002/mc.23103
   PubMed Web of Science ®Google Scholar
• Ariyoshi W, Okinaga T, Chaweewannakorn W, et al. Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33. J Cell Physiol. 2017;232(12):3481–95. doi: 10.1002/jcp.25809
   PubMed Web of Science ®Google Scholar
• Mueller T, Jaffe AS. (2015) soluble ST2 – analytical considerations. Am J Cardiol. 2015;115(7 Suppl):8B–21B. doi: 10.1016/j.amjcard.2015.01.035
   PubMed Web of Science ®Google Scholar
• Moulin D, Donze O, Talabot-Ayer D, et al. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine. 2007;40(3):216–25. doi: 10.1016/j.cyto.2007.09.013
   PubMed Web of Science ®Google Scholar
• Smithgall MD, Comeau MR, Yoon BR, et al. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol. 2008;20(8):1019–30. doi: 10.1093/intimm/dxn060
   PubMed Web of Science ®Google Scholar
• Ribatti D, Vacca A. The role of microenvironment in tumor angiogenesis. Genes Nutr. 2008;3(1):29–34. doi: 10.1007/s12263-008-0076-3
   PubMed Web of Science ®Google Scholar
• Choi YS, Choi HJ, Min JK, et al. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood. 2009;114(14):3117–26. doi: 10.1182/blood-2009-02-203372
   PubMed Web of Science ®Google Scholar
• Chalubinski M, Wojdan K, Luczak E, et al. IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms. Vasc Pharmacol. 2015;73:57–63. doi: 10.1016/j.vph.2015.07.012
   PubMed Web of Science ®Google Scholar
• Zhang Y, Davis C, Shah S, et al. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis. Mol Carcinog. 2017;56(1):272–87. doi: 10.1002/mc.22491
   PubMed Web of Science ®Google Scholar